Pyrantel Pamoate]]>

Risk Factor: C
Class: Anti-infectives/ Anthelmintics

Contents of this page:
Fetal Risk Summary
Breast Feeding Summary
References

Fetal Risk Summary

No reports on the use of this drug in human pregnancy have been located. Shepard cited two studies in which no congenital defects or postnatal effects were observed in pregnant rats fed doses up to 3000 mg/kg or in pregnant rabbits given 1000 mg/kg (1,2).

Breast Feeding Summary

No data are available.

References

]]>

  1. Owaki Y, Sakai T, Momiyama H. Teratological studies on pyrantel pamoate in rats. Oyo Yakuri 1971;5:4150. As cited in Shepard TH. Catalog of Teratogenic Agents. 6th ed. Baltimore, MD: Johns Hopkins University Press, 1989:536.
  2. Owaki Y, Sakai T, Momiyama H. Teratological studies on pyrantel pamoate in rabbits. Oyo Yakuri 1971;5:3339. As cited in Shepard TH. Catalog of Teratogenic Agents. 6th ed. Baltimore, MD: Johns Hopkins University Press, 1989:536.

Please enable JavaScript to view the comments powered by Disqus.blog comments powered by Disqus